DexCom, Inc. vs VNET Group Inc — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while VNET Group Inc trades at $7.51 (market cap $2.14B). The key difference: DexCom, Inc. is far larger — about 15.8× VNET Group Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, VNET Group Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | VNET | |
|---|---|---|
Market Cap | $33.79B | $2.14B |
Sector | Health | Technology |
52-Week High | $89.53 | $14.03 |
52-Week Low | $54.84 | $6.29 |
Enterprise Value | $33.24B | $5.29B |
Trailing returns across standard periods
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →